Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Pharma
Amid Dupixent boom, Sanofi looks hard at its R&D future
Amid a push to win back investor confidence in its R&D trajectory, Sanofi still has significant commercial powder to burn with Dupixent.
Fraiser Kansteiner
Oct 30, 2026 11:50am
AstraZeneca launches $1.5B savings plan to fuel pipeline growth
Oct 30, 2026 10:46am
BMS' Cobenfy underwhelms expectations in Q3 report
Oct 29, 2026 11:35am
For Merck, 2027 is ‘another year of investment’
Oct 29, 2026 11:23am
Apellis buyout fuels Biogen's best quarter since 2020
Oct 28, 2026 11:54am
GSK talks through Hibsago launch as it reports out mixed Q3
Oct 28, 2026 11:05am
